Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$769M |
| 2 |
Meta Platforms (Facebook)
META
|
+$382M |
| 3 |
Roblox
RBLX
|
+$329M |
| 4 |
Tesla
TSLA
|
+$287M |
| 5 |
Qualcomm
QCOM
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$407M |
| 2 |
Visa
V
|
+$345M |
| 3 |
Snowflake
SNOW
|
+$344M |
| 4 |
Micron Technology
MU
|
+$278M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.91% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.02% |
| 4 | Consumer Discretionary | 9.99% |
| 5 | Communication Services | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
JELD-WEN Holding
JELD
$156M
| $1.34M | ﹤0.01% |
53,567
-1,538
| -3% | -$41K |
|
2302
Novartis
NVS
$294B
| $1.34M | ﹤0.01% |
16,379
-496
| -3% | -$44.6K |
|
|
RVNC
2303
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.33M | ﹤0.01% |
47,896
-14,791
| -24% | -$422K |
|
2304
Worthington Enterprises
WOR
$2.87B
| $1.33M | ﹤0.01% |
40,952
-1,775
| -4% | -$64K |
|
|
ALEX
2305
DELISTED
Alexander & Baldwin
ALEX
| $1.33M | ﹤0.01% |
56,755
-147,574
| -72% | -$3.03M |
|
2306
Palomar
PLMR
$3.55B
| $1.33M | ﹤0.01% |
16,425
-412
| -2% | -$34K |
|
2307
PennyMac Financial
PFSI
$3.94B
| $1.32M | ﹤0.01% |
21,675
-2,186
| -9% | -$139K |
|
2308
Foghorn Therapeutics
FHTX
$287M
| $1.32M | ﹤0.01% |
94,940
-94,169
| -50% | -$1.04M |
|
|
CSR
2309
Centerspace
CSR
$956M
| $1.32M | ﹤0.01% |
13,962
+979
| +8% | +$92.1K |
|
2310
Oxford Industries
OXM
$580M
| $1.32M | ﹤0.01% |
14,627
+3,692
| +34% | +$336K |
|
2311
Nu Skin
NUS
$253M
| $1.32M | ﹤0.01% |
32,556
-2,447
| -7% | -$124K |
|
2312
Old Republic International
ORI
$10.5B
| $1.32M | ﹤0.01% |
57,002
-23,404
| -29% | -$579K |
|
2313
Thryv Holdings
THRY
$108M
| $1.32M | ﹤0.01% |
43,835
+39,794
| +985% | +$1.25M |
|
2314
uniQure
QURE
$3.07B
| $1.31M | ﹤0.01% |
41,075
+4,126
| +11% | +$126K |
|
2315
AeroVironment
AVAV
$8.51B
| $1.31M | ﹤0.01% |
15,204
-30,634
| -67% | -$2.97M |
|
2316
ESCO Technologies
ESE
$8.49B
| $1.31M | ﹤0.01% |
17,027
-6,900
| -29% | -$611K |
|
2317
NovaGold Resources
NG
$3.02B
| $1.31M | ﹤0.01% |
190,354
-39,033
| -17% | -$289K |
|
2318
Coty
COTY
$2.49B
| $1.31M | ﹤0.01% |
166,296
+120,525
| +263% | +$1.03M |
|
|
TRIL
2319
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.31M | ﹤0.01% |
74,522
+4,498
| +6% | +$52.6K |
|
2320
Karyopharm Therapeutics
KPTI
$43.3M
| $1.31M | ﹤0.01% |
14,976
-140
| -0.9% | -$14.5K |
|
|
THS
2321
DELISTED
Treehouse Foods
THS
| $1.31M | ﹤0.01% |
32,763
-1,321
| -4% | -$54K |
|
|
CIVI
2322
DELISTED
Civitas Resources
CIVI
| $1.3M | ﹤0.01% |
27,219
-2,927
| -10% | -$120K |
|
2323
Strategic Education
STRA
$1.89B
| $1.3M | ﹤0.01% |
18,437
+42
| +0.2% | +$3.13K |
|
2324
Aligos Therapeutics
ALGS
$29.3M
| $1.3M | ﹤0.01% |
3,350
-510
| -13% | -$202K |
|
2325
Provident Financial Services
PFS
$3.27B
| $1.3M | ﹤0.01% |
55,265
-1,297
| -2% | -$28.6K |
|
Similar funds
Deutsche Bank's Q3 2021 Portfolio in Review
As of Q3 2021, Deutsche Bank held 4,855 positions worth $211B, up 2.4% from $206B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Deutsche Bank's Q3 2021 filing shows 198 new, 1,525 increased, 2,234 reduced and 397 closed positions. Its largest new stake was AfterNext HealthTech Acquisition Corp Units: 1,163,081 shares worth $11.6M. The largest sale was Alexion Pharmaceuticals, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Deutsche Bank's largest Q3 2021 buy was AfterNext HealthTech Acquisition Corp Units: 1,163,081 shares worth $11.6M.
- Deutsche Bank added most to Amazon in Q3 2021, an estimated $769M increase.
- Deutsche Bank's biggest Q3 2021 reduction was Visa, cutting an estimated $345M.
- Deutsche Bank fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $407M.
- Deutsche Bank's ten largest holdings make up 20% of its $211B portfolio in Q3 2021.
- Deutsche Bank opened 198 new positions and closed 397 in Q3 2021.
- Deutsche Bank's portfolio value rose 2.4% quarter-over-quarter to $211B.
Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.